A north central cancer treatment group phase II trial of 9-aminocamptothecin in previously untreated patients with measurable metastatic colorectal carcinoma

Henry C. Pitot, James A. Knost, Michelle R. Mahoney, John Kugler, James E. Krook, Alan K. Hatfield, Daniel J. Sargent, Richard M. Goldberg

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint Dive into the research topics of 'A north central cancer treatment group phase II trial of 9-aminocamptothecin in previously untreated patients with measurable metastatic colorectal carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences